User profiles for Alfred H.J. Kim
 | Alfred HJ KimWashington University School of Medicine Verified email at wustl.edu Cited by 5541 |
[HTML][HTML] Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
[HTML][HTML] The complement system in COVID-19: friend and foe?
…, MK Liszewski, A Coler-Reilly, JP Atkinson, AHJ Kim… - JCI insight, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has resulted in a global pandemic and a disruptive …
syndrome coronavirus-2 (SARS-CoV-2) has resulted in a global pandemic and a disruptive …
[HTML][HTML] COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
The COVID-19 pandemic has brought challenges for people with rheumatic disease in
addition to those faced by the general population, including concerns about higher risks of …
addition to those faced by the general population, including concerns about higher risks of …
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis
Objectives The treatment for COVID-19 often utilizes immune-modulating drugs. These
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …
A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19
Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions,
has garnered widespread attention as a potential treatment for COVID-19 infection. The …
has garnered widespread attention as a potential treatment for COVID-19 infection. The …
SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis
…, C Kasia, A Khilnani, A Kilian, AHJ Kim… - Arthritis & …, 2022 - Wiley Online Library
Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine
and chloroquine, have recently attracted widespread interest as potential therapies for …
and chloroquine, have recently attracted widespread interest as potential therapies for …
Cardiac manifestations of systemic lupus erythematosus
Autoantibodies serve as a diagnostic tool for systemic lupus erythematosus (SLE) and other
autoimmune diseases, but certain autoantibodies are thought to be directly pathogenic in …
autoimmune diseases, but certain autoantibodies are thought to be directly pathogenic in …